Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04578912 · ClinicalTrials.gov registry record · NA

Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics

A NA study of Tourette Syndrome and Tic Disorders, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04578912 is a NA study of Tourette Syndrome and Tic Disorders that has completed, run by University of Minnesota. The registered enrollment target is 50 participants, below the 85-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04578912, a NA study of Tourette Syndrome and Tic Disorders, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The study will examine whether combining Comprehensive Behavioral Intervention for Tics (CBIT) with inhibition of the supplementary motor area (SMA) using transcranial magnetic stimulation (TMS) normalizes activity in the SMA-connected circuits, improves tic suppression ability, and enhances CBIT outcomes in young people with tic disorder. The study will also examine different TMS dosing strategies.

Interventions

  • DEVICE Repetitive Transcranial Magnetic Stimulation (rTMS)
  • BEHAVIORAL Comprehensive Behavioral Intervention for Tics (CBIT)
  • DEVICE Continuous Theta Burst Stimulation (cTBS)

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2020-11-01
Est. Completion 2023-12-31
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT04578912

The ClinicalTrials.gov registry entry for NCT04578912 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 85-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (41% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 3 interventions - of which Repetitive Transcranial Magnetic Stimulation (rTMS) is the first listed.

NCT04578912 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04578912 about?

NCT04578912 is a clinical study titled "Transcranial Magnetic Stimulation to Augment Behavior Therapy for Tics". The study will examine whether combining Comprehensive Behavioral Intervention for Tics (CBIT) with inhibition of the supplementary motor area (SMA) using transcranial magnetic stimulation (TMS) normalizes activity in the SMA-connected circuits, improves tic suppression ability, and enhances CBIT ou...

What is the current status of trial NCT04578912?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2020-11-01. Estimated completion is 2023-12-31.

What conditions does trial NCT04578912 study?

This clinical trial studies the following conditions: Tourette Syndrome, Tic Disorders, Tourette Syndrome in Adolescence, Tics, Tourette Syndrome in Children.

What interventions are being tested in trial NCT04578912?

The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE), Comprehensive Behavioral Intervention for Tics (CBIT) (BEHAVIORAL), Continuous Theta Burst Stimulation (cTBS) (DEVICE).

Who is sponsoring clinical trial NCT04578912?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04578912 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tourette Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.